Tag: prostate cancer

Better Outcomes for Obese Men With Advanced Prostate Cancer

By Amy Norton HealthDay Reporter MONDAY, July 12, 2021 (HealthDay News) — When men have advanced prostate cancer, obesity might offer something of a survival...

Black Men Less Likely to Get Best Prostate Cancer Treatments

By Robert PreidtHealthDay Reporter TUESDAY, June 29, 2021 (HealthDay News) — Black American military veterans with aggressive prostate cancer who would benefit from surgery or...

When to Stop Cancer Screening: Clinicians’ Calculus Varies

Clinicians more often use a strict age cutoff for stopping colon cancer screening than they do for stopping breast and prostate cancer screening, new data...

Rebuilding Trust in Healthcare Key to Recharging Vaccine Uptake

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Left – Dr Richard Baron; Right – Dr Dhruv Khullar Before...

Talking to People About Your Prostate Cancer Diagnosis

About 1 in 8 men learn that they have prostate cancer sometime during their lifetime. In fact, it’s the second leading cause of cancer death...

Targeted Radiotherapy Might Help Fight Advanced Prostate Cancer

By Cara Murez HealthDay Reporter FRIDAY, June 4, 2021 (HealthDay News) — Patients with advanced prostate cancers may have newfound hope: Researchers identified a new...

Things People With Prostate Cancer Wish You Knew

Prostate cancer happens when abnormal cells grow and develop quicker than normal in your prostate. That’s the walnut-shaped gland that makes fluid to...

Nearly 10 Million Cancer Screenings Missed During Pandemic

WEDNESDAY, May 5, 2021 (HealthDay News) — Nearly 10 million cancer screenings have been missed in the United States during the coronavirus pandemic, researchers...

Loneliness in Middle-Aged Men Linked to Increased Cancer Risk

Loneliness among middle-aged men ups their risk of cancer, and being single at the time of diagnosis confers a worse prognosis, suggest results from a...

CCR Score Can Guide Treatment After Radiation in Prostate Cancer

The combined clinical cell-cycle risk (CCR) score — derived from both clinical and genetic factors — can identify patients with intermediate- and high-risk localized prostate...

Liquid vs Tissue Biopsy in Prostate Cancer: Why Not Both?

The genomic landscape of circulating tumor DNA (ctDNA) was comparable to the landscape of tissue biopsies in a large study of patients with metastatic castration-resistant...

MRI-Guided Prostate Biopsy Prevails in PRECISE Trial

Here’s welcome news for men of a certain age: new results support a less invasive approach to investigations for suspicion of prostate cancer. An approach...

Liquid Biopsies Helpful in Prostate Cancer, but Most Not Ready for Routine Use

NEW YORK (Reuters Health) – Liquid biopsies have the potential to guide therapeutic decision making in prostate cancer, but issues such as assay standardization, cost...

Postprostatectomy Urinary Outcomes Vary Widely by Patient and Surgeon

(Reuters Health) – Patient-reported urinary outcomes three months after radical prostatectomy vary by patient and by surgeon, and a new study suggests that outcomes may...

Doctors Underreport Side Effects of Breast Irradiation

There is a substantial mismatch between patient and physician reports of toxicity during radiotherapy for breast cancer, according to an analysis of nearly 10,000 U.S....

Judge Delays Rule That Cuts Pay for Drugs in Docs’ Offices

The Trump administration has failed to persuade a judge of the need to rush the implementation of major changes in payments for drugs administered in...

FDA OKs First Oral Hormone Tx for Advanced Prostate Cancer

The US Food and Drug Administration (FDA) today approved an oral form of androgen deprivation therapy (ADT) known as relugolix (Orgovyx) for the treatment of...

FDA Approves First Agent for PSMA-PET Imaging in Prostate Cancer

A new radioactive diagnostic agent for use in prostate cancer has been approved by the US Food and Drug Administration (FDA). The product, Gallium 68...

‘Hidden’ Prostate Cancer Usually Means Good Outcome

         By Robert Preidt                   HealthDay Reporter              ...

Hold Off Radiotherapy After Prostate Cancer Surgery

Most men who undergo radical prostatectomy can skip adjuvant radiotherapy and can be followed with observation alone. They can undergo early salvage radiotherapy if the...

Global Stomach Cancer Deaths Decline as CRC Deaths Stagnate, Rise

A global analysis of premature deaths from noncommunicable diseases (NCDs) has shown mixed results for gastrointestinal (GI) cancers. The data suggest fewer people are dying...

New Drug for Prostate Cancer: Ipatasertib, an AKT Inhibitor

The investigational kinase inhibitor ipatasertib (Roche), which targets a key cancer metabolic pathway, has shown promise when used in combination with abiraterone (Zytiga) in the...

Genetic Differences by Ancestry and Prostate Cancer Therapies

There are genetic differences when comparing prostate tumors from African American men and European-American men, but none of these differences are of clinical significance for...

Physicians, Patients Need to Know Limits of DNA Privacy Law

Because of the role genetic testing now plays in the management of cancer, and in the identification of risk for the disease, physicians should make...

Does Obesity Reduce Drug Efficacy in Breast Cancer?

Obesity has been shown to have an impact on the risk of developing breast cancer and on prognosis. A new study suggests that it may...